Valuation Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-09			5-day change	1st Jan Change
17.57 ^CNY	-2.12%		-6.79%	+9.74%

12-07	Yiling Pharmaceutical's Qifang Bitong Tablets Placed in China's Insurance Drug List	MT
11-28	Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	30,365	32,746	50,054	38,543	26,748	29,354	-	-
Change	-	7.84%	52.86%	-23%	-30.6%	9.74%	-	-
Enterprise Value (EV) ¹	30,365	32,746	49,007	39,009	25,903	28,929	27,919	27,098
Change	-	7.84%	49.66%	-20.4%	-33.6%	11.68%	-3.49%	-2.94%
P/E ratio	25x	24.4x	21.2x	28.5x	-36.9x	23.9x	20.7x	18.1x
PBR	3.41x	3.61x	4.58x	3.37x	2.62x	2.59x	2.36x	2.14x
PEG	-	2.3x	0.3x	-0.7x	0x	-0x	1.4x	1.3x
Capitalization / Revenue	3.48x	3.24x	3.99x	3.74x	4.11x	3.18x	2.88x	2.51x
EV / Revenue	3.48x	3.24x	3.91x	3.78x	3.98x	3.13x	2.74x	2.32x
EV / EBITDA	17.7x	16.9x	15x	16.8x	-61,383x	17.8x	16.4x	16.2x
EV / EBIT	21.1x	20.9x	17.3x	21.9x	-37.6x	20.6x	17x	14.4x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	0.7143	0.3	0.5	0.3	-	0.2513	0.2909	0.3205
Rate of return	3.92%	1.53%	1.67%	1.3%	-	1.43%	1.66%	1.82%
EPS ²	0.7286	0.8044	1.414	0.8095	-0.4337	0.735	0.8477	0.97
Distribution rate	98%	37.3%	35.4%	37.1%	-	34.2%	34.3%	33%
Net sales ¹	8,736	10,117	12,533	10,318	6,513	9,235	10,199	11,673
EBITDA ¹	1,713	1,939	3,271	2,321	-0.422	1,623	1,706	1,670
EBIT ¹	1,438	1,569	2,830	1,780	-688.9	1,402	1,647	1,887
Net income ¹	1,220	1,344	2,362	1,352	-724.5	1,230	1,418	1,624
Net Debt ¹	-	-	-1,048	465.6	-844.8	-425	-1,435	-2,256
Reference price ²	18.21	19.60	29.96	23.07	16.01	17.57	17.57	17.57
Nbr of stocks (in thousands)	1,667,081	1,670,705	1,670,705	1,670,705	1,670,705	1,670,705	-	-
Announcement Date	2/25/21	4/28/22	4/25/23	4/26/24	4/28/25	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	24.42x	3.2x	18.22x	1.4%	4.24B
BEIJING TONGRENTANG CO., LTD	27.73x	1.74x	10.04x	2.56%	6.44B
DONG-E-E-JIAO CO.,LTD.	17.48x	3.68x	12.33x	5.25%	4.35B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	15.18x	-	-	-	4.33B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	11.63x	-	-	-	3.55B
TASLY PHARMACEUTICAL GROUP CO., LTD	19.83x	2.31x	10.05x	3.55%	3.23B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	15.32x	2.77x	12.25x	4.99%	1.75B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	18.63x	-	-	4.41%	1.69B
Average	18.78x	2.74x	12.58x	3.69%	3.7B
Weighted average by Cap.	19.86x	2.65x	12.46x	3.36%